Indacaterol Maleate/Glycopyrronium Bromide/Mometasone furoate

马来酸茚达特罗/格隆溴铵/莫米松糠酸酯

Report date: 2026/05/24 20:00:34

Base Information

Drug NameIndacaterol Maleate/Glycopyrronium Bromide/Mometasone furoate
Drug Alias NameMometasone/Glycopyrrolate/Indacaterol马来酸茚达特罗格隆溴铵莫米松糠酸酯Glycopyrrolate/indacaterol/mometasone格隆溴铵/莫米松糠酸酯/马来酸茚达特罗Indacaterol/mometasone/Glycopyrrolate +[14] 
ClassificationSmall molecules > Steroids
Mechanisms of ActionBeta-2 adrenergic receptor agonistsGlucocorticoid receptor agonistsMuscarinic acetylcholine receptor antagonists
TargetsMuscarinic acetylcholine receptorBeta-2 adrenergic receptorGlucocorticoid receptor
Therapy Area/IndicationsAsthma
Global Approved IndicationsAsthma
Approved Indications in ChinaAsthma
Original Approved Country/TerritoryJapan
Original Approved Date2020/06/29
Country/TerritoryCzechiaBelgiumBulgaria +[46] 
CombinationsYes Indacaterol MaleateGlycopyrronium BromideMometasone furoate
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesNovartis Pharma Ag
China Registration ClassN/A

Develop Information

Active CompaniesValeo Pharma IncNovartis Pharma AgNovartis Europharm Ltd +[4] 
Inactive CompaniesNovartis Pharma Stein Ag
Active IndicationsAsthma
Inactive IndicationsN/A

Other Information

ATC CodeR03AL
Related LinksN/A